Introduction
Psychogenic non-epileptic seizures (PNES) are paroxysmal events of behaviour that resemble epileptic seizures but are not associated with the ictal changes in brain electrical activity seen with epileptic seizures. PNES have a presumed or known psychological basis and have no identifiable physiological cause. Terms such as non-epileptic seizures, non-epileptic attack disorder, hysterical seizures, pseudoseizures and pseudo-epileptic seizures have also been used to describe PNES. 1 The incidence of PNES is estimated to be 1.4 to 3.3 per 100,000 per year 2, 3 and prevalence has been estimated to be between 2 and 33 per 100,000 4 or approximately 4% of the epilepsy population. 2 Approximately a fifth of patients referred to a ''first-seizure'' service with new onset events have been reported to have PNES. 5 Similarly, 20-25% of all patients referred to a specialist epilepsy clinic have PNES. 3, 6 It is well recognised that epilepsy is associated with an increased risk of motor vehicle accidents. 7 The Driver and Vehicle
Licensing Agency (DVLA) is a government agency in the United Kingdom involved in issuing licences and maintaining databases of registered vehicles in the UK. As part of the licensing procedure, their Medical Advisers provide guidance on fitness to drive in a number of medical illnesses, including epilepsy. Information provided by patients and treating clinicians is then used to determine a patient's suitability to hold a licence by DVLA Medical Advisers. The DVLA also provides advice on ''non-epileptic seizure disorder'' and driving, by advising that: ''Licence will be issued after medical reports confirm that behavioural disturbances have been satisfactorily controlled.'' 8 However, the criteria for satisfactory control are not specified. Previous reports have shown that there is no clear consensus amongst epileptologists in Germany or the United States on driving restrictions in PNES, with insufficient evidence in the literature being cited as a reason for the lack of consensus. 9 One study from the United States studied the driving records of 20 patients with proven PNES in Wisconsin and compared the number of motor crashes in the PNES group with control data of other drivers from that year. 10 Eight crashes were reported in the PNES group, but this was not statistically significant when compared to a control population at the same time. This study had limitations and in particular, it was not controlled for distance travelled but it suggests that, unlike patients with epilepsy, PNES patients do not have an increased risk of motor vehicle accident. 10 The aim of our study was to describe current practice amongst neurologists and specialists in epilepsy in the United Kingdom The Driver and Vehicle Licensing Agency (DVLA) in the United Kingdom provides guidance on fitness to drive for patients with a number of medical illnesses, including epilepsy and psychogenic non-epileptic seizures (PNES).
The Association of British Neurologists circulates a monthly electronic newsletter to its membership by email. We used this newsletter to survey its recipients on the driving advice they offer patients with PNES, and their awareness of current DVLA guidelines.
54 replies were received (19/54 were epilepsy specialists). 11/54 respondents were unaware of any DVLA guidance regarding PNES. Of 43/54 aware of DVLA guidance, only 7% felt that it was sufficient. 40% of respondents did not recommend any driving restriction. 68% of epilepsy specialists recommended driving restriction as compared to 54% of non-epilepsy specialists. 2 respondents reported patients with PNES who had an accident as a consequence of a non-epileptic attack. The risk of motor vehicle accidents in patients with PNES needs further study. Until the establishment of evidence-based guidelines, there is a need to seek consensus and provide sufficient guidance regarding driving for both patients with PNES and their clinicians.
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regarding the driving advice they provide patients with PNES, and whether they believed that the current DVLA guidance regarding patients with PNES was sufficient.
Methods
The Association of British Neurologists circulates a monthly electronic newsletter to its membership, who are clinicians with an interest in neurology and include consultant neurologists, epilepsy specialists (both neurologists and non-neurologists), trainees and researchers in neurology, as well as associate specialists and general practitioners interested in neurological disorders. We invited recipients of the newsletter to answer an anonymised, internet based survey on non-epileptic attacks between January 2010 and February 2010 (Fig. 1) by following a link in the electronic newsletter. 11 The survey included 10 questions as listed in Fig. 1 . Data was collected and returned by the web service.
Results
1319 electronic newsletters were sent and 54 replies were received. 72% of respondents were consultant neurologists, 24% were specialist or specialty registrars (trainees) in neurology or neurophysiology and the remainder were clinicians with an interest in neurological disorders (associate specialists, general practitioners or researchers). The majority of responses (35) were from England (64%), followed by 17 from Scotland (32%) and 2 from Northern Ireland (4%). 19/54 (35%) of respondents described themselves as having a specialist interest in epilepsy.
Results are summarised in Table 1 . 2/54 respondents reported patients with PNES who had a motor vehicle accident as a consequence of an attack.
13/19 epilepsy specialists reported advising patients not to drive (6/19 did not advise driving restriction). 5/13 specified driving restrictions from 1 month to 1 year. 4/13 provided individualised advice on a case-by-case basis and 4/13 left the decision on duration of driving restriction to the DVLA (not making any personal recommendation on duration themselves). 19/35 non-epilepsy specialist clinicians reported advising patients not to drive (16/35 did not advise driving restriction). 9/19 (47%) specified driving restrictions from 3 months to 1 year, 5/19 (26%) provided individualised advice on a case-by-case basis and 5/ 19 (26%) left the decision on duration of driving restriction completely to the DVLA.
Of 43/54 respondents who reported being aware of current DVLA guidance regarding patients with PNES, 87% (13/15) of epilepsy specialists and 96% (27/28) of non-epilepsy specialists felt that current DVLA guidance was insufficient.
Amongst epilepsy specialists, 28% (5/18) of respondents felt that driving restrictions for patients with PNES should be less than epilepsy, 50% (9/18) felt they should be the same as epilepsy, 22% (4/18) answered that no restrictions should apply and one did not respond. 38% (13/34) of non-epilepsy specialists stated that driving restrictions should be less than epilepsy, 35% (12/34) thought that restrictions should be the same while 26% (9/34) thought that no restrictions should apply. One non-epilepsy specialist did not respond. No respondent felt that driving restrictions in PNES should be more than for patients with epilepsy.
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"We would be grateful if you could complete this short survey looking at driving advice given to patients with non-epileptic attacks. It will only take 2 minutes to complete and your help will be much appreciated:" 15/19 epilepsy specialists (78%) and 33/35 non-epilepsy specialists (94%) felt that driving restrictions could potentially influence prognosis in non-epileptic attacks.
Discussion
The results of our national survey of clinical practice amongst clinicians with an interest in neurological disorders, including epilepsy specialists, in the United Kingdom demonstrate a wide variation in practice. 40.7% of clinicians do not recommend driving restriction in patients with PNES. If driving restrictions are personally recommended by a clinician, they may vary from one month to one year. Other clinicians leave the decision regarding duration completely to the DVLA and do not personally suggest a fixed period of driving cessation. There does not appear to be significant difference in practice between epilepsy specialists and non-epilepsy specialists. The reasons for this variation in practice were not assessed in this study. However, they are likely to be multi-factorial. Awareness of the previously published literature on the subject from the USA and Germany may have influenced some respondents, which suggests assessment is performed on an individual basis. 9, 10 The DVLA defines distinct periods of driving cessation in neurological disorders such as stroke, first seizure and epilepsy. The DVLA advice in such disorders is not influenced by clinician's assessment of severity of illness or recovery after illness. In contrast, in PNES, the DVLA guidance puts the onus on the clinician by suggesting that the duration of driving restriction depends upon satisfactory control as determined by the clinician. It is possible that clinicians have varying degrees of experience and confidence in determining what might constitute ''satisfactory control''. The DVLA guidance does not clarify if satisfactory control implies complete cessation of all attacks or cessation of what may be perceived to be high risk attacks (possibly in contrast to PNES attacks which occur solely in set circumstances unlikely to be replicated whilst driving). It is also possible that awareness amongst some respondents of individuals with PNES who have reported accidents (as in 2/54 of our respondents) influences practice.
Additionally, PNES are varied with motor (major motor, minor motor and atonic) and non-motor types. Patients may have a single or multiple types of PNES. 12 This may potentially influence recommendations by clinicians in individual patients. However, sub-categories of epileptic seizure types do not influence DVLA guidance on driving with epilepsy, with the exception of purely nocturnal seizures. For example, patients with purely reflex seizures in set circumstances not likely to be replicated whilst driving are not allowed to drive by the DVLA. Similarly, patients with solely simple partial seizures with preserved consciousness and no loss of motor control are restricted from driving. A previous report described motor vehicle accidents in patients with PNES, but did not assess whether the documented crashes were a direct result of a non-epileptic attack. The number of crashes was not significantly different from expected. 10 In our survey, 2 clinicians reported patients who had a motor vehicle accident as a consequence of a non-epileptic seizure. The nature and severity of these accidents is not known, but this suggests that PNES may have an impact on an individual's ability to drive safely. Future research in this area is needed. Significantly, 11/54 (20.3%) of our respondents were unaware of the existence of any DVLA guidance regarding PNES. Only 3/43 respondents who were aware of DVLA guidance regarding PNES thought it was sufficient. This highlights the need for the DVLA to review and consider the existing literature, and provide clear guidance regarding driving and PNES. In particular, the DVLA should specify the definition of ''satisfactory control'' of PNES. In addition, current and future guidance must be disseminated amongst clinicians with an interest in neurological disorders.
48 of our 54 respondents felt that driving restrictions could potentially influence prognosis in PNES, but whether this effect was positive or negative was not considered. It is possible that in some individuals with PNES, the enforcement of driving restriction may positively influence prognosis, as some individuals may potentially be more motivated to accept diagnosis and engage with management strategies. On the other hand, it is also possible that driving restrictions could negatively influence prognosis as a consequence of the impact on quality of life and the ability to work affected by driving restriction enforcement. Further work in this area would be informative. Our survey had a number of limitations, including the small sample size and responder bias. We had only 54 respondents from a large number of recipients of the newsletter. However, it must be noted that a significant proportion of the newsletter audience have specialist interests, which preclude them from seeing a significant number of patients with PNES. It is therefore likely that the respondents of our survey were clinicians who do actually treat patients with PNES and therefore our survey is probably a reflection of actual practice in the United Kingdom.
In conclusion, despite its limitations, this study clearly demonstrates that neurologists and epilepsy specialists in the United Kingdom do not regard current DVLA advice regarding PNES as sufficient. Our survey also reports that PNES attacks may be reported in association with motor vehicle accidents. The risk of motor vehicle accidents in patients with PNES therefore needs to be studied in a more systematic manner to allow for the development of appropriate guidelines for patients with PNES, and their clinicians.
